Immunotherapy Biomarkers: Searching for a cure

07/28/2016  Dr. Alex Forrest-Hay, Director, Affymetrix

Abstract: Cancer immunotherapies are rapidly changing traditional treatment paradigms and expanding the therapeutic landscape for cancer patients. Despite the current success of these therapies, not all patients respond to immunotherapy and even those that do often experience toxicities. There is a growing need to identify predictive and prognostic biomarkers that enhance our understanding of the mechanisms underlying the complex interactions between the immune system and cancer. This presentation will discuss new techniques to uncover biomarkers in tumor tissue, liquid biopsies, and single cells.

Register at: